incb039110
Showing 1 - 3 of 3
Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)
Active, not recruiting
- Melanoma
- Trametinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 1, 2021
Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in United States (INCB052793, gemcitabine, nab-paclitaxel)
Pruritis Trial (INCB039110)
Withdrawn
- Pruritis
- INCB039110
- (no location specified)
May 10, 2019